Niagen Bioscience (NAGE) Times Interest Earned (2010 - 2026)
Niagen Bioscience's (NAGE) quarterly Times Interest Earned came in at $3.74 in Q1 2026, up 216.14% year-on-year from $1.18 in Q1 2025, and up 158.27% on a QoQ basis from -$6.42 in Q4 2025.
Niagen Bioscience (NAGE) Times Interest Earned (2010 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has 17 years of Times Interest Earned data on file, last reported at $3.74 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 216.14% year-over-year to $3.74 in Q1 2026; TTM through Mar 2026 was $31.08, a 846.68% increase from a year earlier, with the FY2025 full-year figure at $0.4, up 130.47% from the prior year.
- Times Interest Earned for Q1 2026 stood at $3.74, up from -$6.42 in the prior quarter.
- Over the last five years, Times Interest Earned for NAGE reached as high as $29.38 in Q4 2024 and fell as low as -$15.53 in Q1 2022.
- Historically, Times Interest Earned has averaged $0.13 across 5 years, with a median of -$0.52 in 2023.
- On a YoY basis, Times Interest Earned climbed as much as 1884.05% in 2024 and fell as far as 256.16% in 2024.
- Year by year, Times Interest Earned stood at -$10.7 in 2022, then soared by 84.6% to -$1.65 in 2023, then soared by 1884.05% to $29.38 in 2024, then slumped by 121.86% to -$6.42 in 2025, then soared by 158.27% to $3.74 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were $3.74 in Q1 2026, -$6.42 in Q4 2025, and $6.45 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn | 3.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.74 |
| Dec 31, 2025 | -6.42 |
| Sep 30, 2025 | 6.45 |
| Jun 30, 2025 | 0.82 |
| Mar 31, 2025 | 1.18 |
| Dec 31, 2024 | 29.38 |
| Sep 30, 2024 | 0.51 |
| Jun 30, 2024 | -1.04 |
| Mar 31, 2024 | -1.49 |
| Dec 31, 2023 | -1.65 |
| Sep 30, 2023 | -0.27 |
| Jun 30, 2023 | -0.52 |
| Mar 31, 2023 | -0.42 |
| Dec 31, 2022 | -10.70 |
| Sep 30, 2022 | -0.61 |
| Jun 30, 2022 | -1.21 |
| Mar 31, 2022 | -15.53 |
| Dec 31, 2021 | 11.29 |
| Sep 30, 2021 | -10.58 |
| Jun 30, 2021 | -1.34 |